Activity of afatinib/cetuximab in patients (pts) with EGFR-mutant non-small cell lung cancer (NSCLC) and acquired resistance (AR) to EGFR inhibitors Meeting Abstract
| Authors: | Janjigian, Y. Y.; Smit, E. F.; Horn, L.; Groen, H. J. M.; Camidge, D. R.; Gettinger, S.; Fu, Y.; Denis, L. J.; Miller, V.; Pao, W. |
| Abstract Title: | Activity of afatinib/cetuximab in patients (pts) with EGFR-mutant non-small cell lung cancer (NSCLC) and acquired resistance (AR) to EGFR inhibitors |
| Meeting Title: | 37th Congress of the European Society for Medical Oncology (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 23 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2012 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2012-09-01 |
| Start Page: | ix401 |
| Language: | English |
| ACCESSION: | WOS:000309409002163 |
| PROVIDER: | wos |
| PUBMED: | 23012731 |
| DOI: | 10.1093/annonc/mds409 |
| Notes: | Meeting Abstract: 1227O -- "Source: Wos" |
